Wider access to quality-assured rifapentine-based regimens is needed to accelerate tuberculosis prevention and care globally

Global access to rifapentine is essential to implement the latest WHO recommendations on treatment of TB infection and disease. Measures to increase access to rifapentine include strengthening regulatory reliance practices. https://bit.ly/3xNDwID

Detalles Bibliográficos
Autores principales: Masini, Tiziana, Kanchar, Avinash, Mirzayev, Fuad, Viney, Kerri, Yedilbayev, Askar, Zignol, Matteo, Falzon, Dennis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403394/
https://www.ncbi.nlm.nih.gov/pubmed/35777762
http://dx.doi.org/10.1183/13993003.01227-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403394/
https://www.ncbi.nlm.nih.gov/pubmed/35777762
http://dx.doi.org/10.1183/13993003.01227-2022

Ejemplares similares